17β-Estradiol sensitizes ovarian surface epithelium to transformation by suppressing Disabled-2 expression

Estrogen replacement therapy increases the risk of human ovarian cancer and exogenous estradiol accelerates the onset of ovarian cancer in mouse models. This study uses primary cultures of mouse ovarian surface epithelium (OSE) to demonstrate that one possible mechanism by which estrogen accelerates...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Scientific reports Jg. 7; H. 1; S. 16702 - 12
Hauptverfasser: Vuong, Nhung H., Salah Salah, Omar, Vanderhyden, Barbara C.
Format: Journal Article
Sprache:Englisch
Veröffentlicht: London Nature Publishing Group UK 01.12.2017
Nature Publishing Group
Schlagworte:
ISSN:2045-2322, 2045-2322
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract Estrogen replacement therapy increases the risk of human ovarian cancer and exogenous estradiol accelerates the onset of ovarian cancer in mouse models. This study uses primary cultures of mouse ovarian surface epithelium (OSE) to demonstrate that one possible mechanism by which estrogen accelerates the initiation of ovarian cancer is by up-regulation of microRNA-378 via the ESR1 pathway to result in the down-regulation of a tumour suppressor called Disabled-2 ( Dab2 ). Estrogen suppression of Dab2 was reproducible in vivo and across many cell types including mouse oviductal epithelium and primary cultures of human ovarian cancer cells. Suppression of Dab2 resulted in increased proliferation, loss of contact inhibition, morphological dysplasia, and resistance to oncogene-induced senescence – all factors that can sensitize OSE to transformation. Given that DAB2 is highly expressed in healthy human OSE and is absent in the majority of ovarian tumours, this study has taken the first steps to provide a mechanistic explanation for how estrogen therapy may play a role in the initiation of ovarian cancer.
AbstractList Estrogen replacement therapy increases the risk of human ovarian cancer and exogenous estradiol accelerates the onset of ovarian cancer in mouse models. This study uses primary cultures of mouse ovarian surface epithelium (OSE) to demonstrate that one possible mechanism by which estrogen accelerates the initiation of ovarian cancer is by up-regulation of microRNA-378 via the ESR1 pathway to result in the down-regulation of a tumour suppressor called Disabled-2 ( Dab2 ). Estrogen suppression of Dab2 was reproducible in vivo and across many cell types including mouse oviductal epithelium and primary cultures of human ovarian cancer cells. Suppression of Dab2 resulted in increased proliferation, loss of contact inhibition, morphological dysplasia, and resistance to oncogene-induced senescence – all factors that can sensitize OSE to transformation. Given that DAB2 is highly expressed in healthy human OSE and is absent in the majority of ovarian tumours, this study has taken the first steps to provide a mechanistic explanation for how estrogen therapy may play a role in the initiation of ovarian cancer.
Estrogen replacement therapy increases the risk of human ovarian cancer and exogenous estradiol accelerates the onset of ovarian cancer in mouse models. This study uses primary cultures of mouse ovarian surface epithelium (OSE) to demonstrate that one possible mechanism by which estrogen accelerates the initiation of ovarian cancer is by up-regulation of microRNA-378 via the ESR1 pathway to result in the down-regulation of a tumour suppressor called Disabled-2 (Dab2). Estrogen suppression of Dab2 was reproducible in vivo and across many cell types including mouse oviductal epithelium and primary cultures of human ovarian cancer cells. Suppression of Dab2 resulted in increased proliferation, loss of contact inhibition, morphological dysplasia, and resistance to oncogene-induced senescence - all factors that can sensitize OSE to transformation. Given that DAB2 is highly expressed in healthy human OSE and is absent in the majority of ovarian tumours, this study has taken the first steps to provide a mechanistic explanation for how estrogen therapy may play a role in the initiation of ovarian cancer.
Estrogen replacement therapy increases the risk of human ovarian cancer and exogenous estradiol accelerates the onset of ovarian cancer in mouse models. This study uses primary cultures of mouse ovarian surface epithelium (OSE) to demonstrate that one possible mechanism by which estrogen accelerates the initiation of ovarian cancer is by up-regulation of microRNA-378 via the ESR1 pathway to result in the down-regulation of a tumour suppressor called Disabled-2 (Dab2). Estrogen suppression of Dab2 was reproducible in vivo and across many cell types including mouse oviductal epithelium and primary cultures of human ovarian cancer cells. Suppression of Dab2 resulted in increased proliferation, loss of contact inhibition, morphological dysplasia, and resistance to oncogene-induced senescence - all factors that can sensitize OSE to transformation. Given that DAB2 is highly expressed in healthy human OSE and is absent in the majority of ovarian tumours, this study has taken the first steps to provide a mechanistic explanation for how estrogen therapy may play a role in the initiation of ovarian cancer.Estrogen replacement therapy increases the risk of human ovarian cancer and exogenous estradiol accelerates the onset of ovarian cancer in mouse models. This study uses primary cultures of mouse ovarian surface epithelium (OSE) to demonstrate that one possible mechanism by which estrogen accelerates the initiation of ovarian cancer is by up-regulation of microRNA-378 via the ESR1 pathway to result in the down-regulation of a tumour suppressor called Disabled-2 (Dab2). Estrogen suppression of Dab2 was reproducible in vivo and across many cell types including mouse oviductal epithelium and primary cultures of human ovarian cancer cells. Suppression of Dab2 resulted in increased proliferation, loss of contact inhibition, morphological dysplasia, and resistance to oncogene-induced senescence - all factors that can sensitize OSE to transformation. Given that DAB2 is highly expressed in healthy human OSE and is absent in the majority of ovarian tumours, this study has taken the first steps to provide a mechanistic explanation for how estrogen therapy may play a role in the initiation of ovarian cancer.
ArticleNumber 16702
Author Vanderhyden, Barbara C.
Vuong, Nhung H.
Salah Salah, Omar
Author_xml – sequence: 1
  givenname: Nhung H.
  surname: Vuong
  fullname: Vuong, Nhung H.
  organization: Department of Cellular and Molecular Medicine, University of Ottawa, Cancer Therapeutics Program, Ottawa Hospital Research Institute
– sequence: 2
  givenname: Omar
  surname: Salah Salah
  fullname: Salah Salah, Omar
  organization: Cancer Therapeutics Program, Ottawa Hospital Research Institute
– sequence: 3
  givenname: Barbara C.
  surname: Vanderhyden
  fullname: Vanderhyden, Barbara C.
  email: bvanderhyden@ohri.ca
  organization: Department of Cellular and Molecular Medicine, University of Ottawa, Cancer Therapeutics Program, Ottawa Hospital Research Institute
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29196616$$D View this record in MEDLINE/PubMed
BookMark eNp9kctu1TAURS1UREvpDzBAkZgwCfiVhydIqJSHVIkJjK0T35Nbl8QOPklF-ax-SL8JtynVpRJ4Ystee3sf7adsL8SAjD0X_LXgqn1DWlSmLbloSlFLYUr5iB1IrqtSKin3ds777IjonOdVSaOFecL2pRGmrkV9wL6L5vqqPKE5wcbHoSAM5Gf_C6mIF5A8hIKW1IPDAic_n-Hgl7GYY5EFgfqYRph9DEV3mblpSkjkw7Z47wm6ATelLPDnehvDM_a4h4Hw6G4_ZN8-nHw9_lSefvn4-fjdael0w-cSeA9QNYgKNqg7QFlrANmC7iqnK6l514PQvauMUqpvTQe84a43XLpGOqUO2dvVd1q6ETcOQw472Cn5EdKljeDt3y_Bn9ltvLBVI0SrTDZ4dWeQ4o8FabajJ4fDAAHjQlaYRtRt26g6oy8foOdxSSGPd0Nx05qa80y92E10H-VPDxmQK-BSJErY3yOC25u-7dq3zX3b276tzKL2gcj5-baOPJUf_i9Vq5TyP2GLaSf2v1W_AWnfwpQ
CitedBy_id crossref_primary_10_1093_biolre_ioz134
crossref_primary_10_1038_s41598_020_66559_9
crossref_primary_10_3390_ijms24010696
crossref_primary_10_1371_journal_pgen_1007788
crossref_primary_10_1007_s11033_024_09653_9
crossref_primary_10_3390_molecules25215214
crossref_primary_10_1002_mco2_475
crossref_primary_10_1093_molehr_gaad006
Cites_doi 10.1016/S0140-6736(14)61687-1
10.1016/J.Bpobgyn.2016.08.006
10.1371/journal.pone.0020610
10.1016/j.ceb.2012.06.009
10.1074/jbc.M611356200
10.1155/2016/7348239
10.1210/me.2003-0441
10.3109/09513590009167686
10.1016/j.steroids.2012.02.015
10.1371/journal.pone.0095987
10.2353/ajpath.2006.060036
10.1016/J.Mce.2015.01.035
10.1016/S0092-8674(00)81902-9
10.1006/dbio.2002.0810
10.1093/emboj/cdg286
10.1016/J.Ygyno.2013.03.021
10.1093/ageing/afv069
10.1016/j.placenta.2011.12.008
10.1038/sj.onc.1210950
10.1158/1078-0432.CCR-07-4959
10.1016/S1016-8478(23)13119-0
10.1093/Hmg/Ddv101
10.1083/jcb.142.2.557
10.1096/Fj.201601128r
10.1677/jme.0.0320615
10.1038/onc.2013.381
10.1016/S0140-6736(71)92335-X
10.1002/cncr.11847
10.4103/1947-2714.94940
10.1186/1471-213X-13-39
10.1038/sj.bjc.6604002
10.1038/ncomms12645
10.1038/nrendo.2013.203
10.1210/en.2005-1629
10.1038/sj.onc.1202649
10.1530/ERC-11-0107
10.1155/2015/916585
10.1038/onc.2011.269
10.1095/biolreprod.113.108829
10.1210/er.22.2.255
10.3389/fonc.2014.00053
10.1038/nrc3622
10.1007/978-3-642-30406-4_14
10.1210/en.2009-0602
10.1096/fj.10-163428
10.1007/s12672-012-0102-1
10.1016/j.jneumeth.2008.05.003
10.1371/journal.pone.0110737
10.1210/endo.142.6.8144
10.1186/1477-7827-8-98
10.1093/biolreprod/87.s1.80
10.2174/138920209788185289
10.1093/emboj/21.7.1555
ContentType Journal Article
Copyright The Author(s) 2017
2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2017
– notice: 2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88A
88E
88I
8FE
8FH
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M2P
M7P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOI 10.1038/s41598-017-16219-2
DatabaseName Open Access资源_Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection (ProQuest)
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest SciTech Premium Collection Natural Science Collection Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Collection (ProQuest)
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
Health & Medical Collection (Alumni Edition)
Medical Database
Science Database
Biological Science Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest - Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList CrossRef

MEDLINE
MEDLINE - Academic
Publicly Available Content Database

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: PIMPY
  name: Publicly Available Content Database
  url: http://search.proquest.com/publiccontent
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2045-2322
EndPage 12
ExternalDocumentID PMC5711839
29196616
10_1038_s41598_017_16219_2
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: CIHR
GroupedDBID 0R~
3V.
4.4
53G
5VS
7X7
88A
88E
88I
8FE
8FH
8FI
8FJ
AAFWJ
AAJSJ
AAKDD
ABDBF
ABUWG
ACGFS
ACSMW
ACUHS
ADBBV
ADRAZ
AENEX
AEUYN
AFKRA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
DIK
DWQXO
EBD
EBLON
EBS
EJD
ESX
FYUFA
GNUQQ
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
KQ8
LK8
M0L
M1P
M2P
M48
M7P
M~E
NAO
OK1
PIMPY
PQQKQ
PROAC
PSQYO
RNT
RNTTT
RPM
SNYQT
UKHRP
AASML
AAYXX
AFFHD
AFPKN
CITATION
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
CGR
CUY
CVF
ECM
EIF
NPM
7XB
8FK
K9.
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c470t-a0faa57ee3ade4bae264aa28a4b5c45240bfa14fc59333f89ba070cf902c72c33
IEDL.DBID M7P
ISICitedReferencesCount 9
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000416938200010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2045-2322
IngestDate Tue Nov 04 01:53:27 EST 2025
Fri Sep 05 12:57:07 EDT 2025
Tue Oct 07 07:29:29 EDT 2025
Mon Jul 21 06:05:51 EDT 2025
Tue Nov 18 21:55:45 EST 2025
Sat Nov 29 03:58:56 EST 2025
Fri Feb 21 02:40:34 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c470t-a0faa57ee3ade4bae264aa28a4b5c45240bfa14fc59333f89ba070cf902c72c33
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://www.proquest.com/docview/1970989600?pq-origsite=%requestingapplication%
PMID 29196616
PQID 1970989600
PQPubID 2041939
PageCount 12
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5711839
proquest_miscellaneous_1971688736
proquest_journals_1970989600
pubmed_primary_29196616
crossref_primary_10_1038_s41598_017_16219_2
crossref_citationtrail_10_1038_s41598_017_16219_2
springer_journals_10_1038_s41598_017_16219_2
PublicationCentury 2000
PublicationDate 20171201
2017-12-01
PublicationDateYYYYMMDD 2017-12-01
PublicationDate_xml – month: 12
  year: 2017
  text: 20171201
  day: 1
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Scientific reports
PublicationTitleAbbrev Sci Rep
PublicationTitleAlternate Sci Rep
PublicationYear 2017
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References LanoixDStability of reference proteins in human placenta: general protein stains are the benchmarkPlacenta2012331511561:CAS:528:DC%2BC38Xit1eisLw%3D10.1016/j.placenta.2011.12.00822244735
OkadaARole of Foxj1 and estrogen receptor alpha in ciliated epithelial cell differentiation of the neonatal oviductJ. Mol. Endocrinol.2004326156251:CAS:528:DC%2BD2cXlslWjt7w%3D10.1677/jme.0.032061515171704
YangD-HDisabled-2 heterozygous mice are predisposed to endometrial and ovarian tumorigenesis and exhibit sex-biased embryonic lethality in a P53-null backgroundThe American Journal Of Pathology20061692582671:CAS:528:DC%2BD28XnslSntb8%3D10.2353/ajpath.2006.060036168163781698752
St CroixBE-cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitorp27(Kip1)The Journal Of Cell Biology199814255757110.1083/jcb.142.2.557
ChoiKCKangSKTaiCJAuerspergNLeungPCEstradiol up-regulates antiapoptotic Bcl-2 messenger ribonucleic acid and protein in tumorigenic ovarian surface epithelium cellsEndocrinology2001142235123601:CAS:528:DC%2BD3MXjvFGgu7Y%3D10.1210/endo.142.6.814411356682
Collaborative Group On Epidemiological Studies Of Ovarian Cancer. Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies. Lancet385, 1835–1842 (2015).
Klinge, C. M. miRNAs regulated by estrogens, tamoxifen, and endocrine disruptors and their downstream gene targets. Molecular And Cellular Endocrinology, https://doi.org/10.1016/J.Mce.2015.01.035 (2015).
SerranoMLinAWMccurrachMEBeachDLoweSWOncogenic Ras Provokes premature cell senescence associated with accumulation of P53 and P16ink4aCell1997885936021:CAS:528:DyaK2sXhvVSit7k%3D10.1016/S0092-8674(00)81902-99054499
HewittSCBiological and biochemical consequences of global deletion of exon 3 from the ER alpha geneFaseb J.201024466046671:CAS:528:DC%2BC3cXhsFOms7zO10.1096/fj.10-163428206679772992373
PlainoLOvarian follicular fluid contains immunoreactive estriol: lack of correlation with estradiol concentrationsGynecol. Endocrinol.2000142312351:STN:280:DC%2BD3M7ltVKjtA%3D%3D10.3109/0951359000916768611075291
ZhangZChenYTangJXieXFrequent loss expression of Dab2 and promotor hypermethylation in human cancers: a meta-analysis and systematic reviewPak J Med Sci201430432437247721573999024
DuLMir-93-directed downregulation of Dab2 defines a novel oncogenic pathway in lung cancerOncogene201433430743151:CAS:528:DC%2BC3sXhsVeqsLrI10.1038/onc.2013.38124037530
RolandIHLoss of surface and cyst epithelial basement membranes and preneoplastic morphologic changes in prophylactic oophorectomiesCancer2003982607262310.1002/cncr.1184714669280
YangDHDisabled-2 is essential for endodermal cell positioning and structure formation during mouse embryogenesisDev. Biol.200225127441:CAS:528:DC%2BD38XotFGgsbo%3D10.1006/dbio.2002.081012413896
GamwellLFCollinsOVanderhydenBCThe mouse ovarian surface epithelium contains a population of Ly6a (Sca-1) expressing progenitor cells that are regulated by ovulation-associated factorsBiology Of Reproduction2012878010.1093/biolreprod/87.s1.8022914315
McclatcheyAIYapASContact inhibition (of proliferation) reduxCurr. Opin. Cell Biol.2012246856941:CAS:528:DC%2BC38XhtVyktL7J10.1016/j.ceb.2012.06.00922835462
Torre DellaSBenedusiVFontanaRMaggiAEnergy metabolism and fertility - a balance preserved for female healthNature Reviews Endocrinology201410132310.1038/nrendo.2013.203
Courtois-CoxSJonesSLCichowskiKMany roads lead to oncogene-induced senescenceOncogene200827280128091:CAS:528:DC%2BD1cXltlSgs7w%3D10.1038/sj.onc.121095018193093
HocevarBAHowePHRegulation of the Wnt signaling pathway by Disabled-2 (Dab2)The Embo Journal200322308430941:CAS:528:DC%2BD3sXks1Wru74%3D10.1093/emboj/cdg28612805222162138
SassariniJLumsdenMAOestrogen replacement in postmenopausal womenAge Ageing20154455155810.1093/ageing/afv06926070875
MccloskeyCWA new spontaneously transformed syngeneic model of high-grade serous ovarian cancer with a tumor-initiating cell populationFront Oncol201445310.3389/fonc.2014.00053246727743957277
FathallaMFIncessant ovulation-a factor in ovarian neoplasia?Lancet197121631:STN:280:DyaE3M3ls12ltw%3D%3D10.1016/S0140-6736(71)92335-X4104488
Webb, P. M. & Jordan, S. J. Epidemiology of epithelial ovarian cancer. Best Pract Res Clin Obstet Gynaecol, https://doi.org/10.1016/J.Bpobgyn.2016.08.006 (2016).
BourdeauVGenome-wide identification of high-affinity estrogen response elements in human and mouseMolecular Endocrinology200418141114271:CAS:528:DC%2BD2cXksl2ju7c%3D10.1210/me.2003-044115001666
AldridgeGMPodrebaracDMGreenoughWTWeilerIJThe use of total protein stains as loading controls: an alternative to high-abundance single-protein controls in semi-quantitative immunoblottingJ. Neurosci. Methods20081722502541:CAS:528:DC%2BD1cXosVyls7w%3D10.1016/j.jneumeth.2008.05.003185717322567873
Auersperg, N. Ovarian surface epithelium as a source of ovarian cancers: unwarranted speculation or evidence-based hypothesis? Gynecologic Oncology 1–6, https://doi.org/10.1016/J.Ygyno.2013.03.021 (2013).
FerraroLEffects of oestrogen on microrna expression in hormone-responsive breast cancer cellsHorm Canc2012365781:CAS:528:DC%2BC38XmsF2msrk%3D10.1007/s12672-012-0102-1
MooreRCaiKQTaoWSmithERXuXXdifferential requirement for Dab2 in the development of embryonic and extra-embryonic tissuesBmc Developmental Biology20131310.1186/1471-213X-13-39241680303924344
GulliverLSMHurstPRRepeat estradiol exposure differentially regulates protein expression patterns for estrogen receptor and e-cadherin in older mouse ovarian surface epithelium: implications for replacement and adjuvant hormone therapies?Steroids2012776746851:CAS:528:DC%2BC38Xkt1ymtrw%3D10.1016/j.steroids.2012.02.01522406420
Coetzee, S. G. et al. Cell type specific enrichment of risk associated regulatory elements at ovarian cancer susceptibility loci. Hum. Mol. Genet. https://doi.org/10.1093/Hmg/Ddv101 (2015).
YangDHXuXXdisabled-2 is an epithelial surface positioning geneJ. Biol. Chem.200728213114131221:CAS:528:DC%2BD2sXksVShsLo%3D10.1074/jbc.M61135620017339320
ChaoARegulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2Oncogene2012317647751:CAS:528:DC%2BC3MXotlCktLw%3D10.1038/onc.2011.26921725366
HongSHExpression of estrogen receptor-alpha and -beta, glucocorticoid receptor, and progesterone receptor genes in human embryonic stem cells and embryoid bodiesMol. Cells2004183203251:CAS:528:DC%2BD2MXpsFartA%3D%3D15650328
LavioletteLA17β-Estradiol accelerates tumor onset and decreases survival in a transgenic mouse model of ovarian cancerEndocrinology20101519299381:CAS:528:DC%2BC3cXjvVKqsL8%3D10.1210/en.2009-060220056833
American Cancer Society. Cancer Facts And Figures 2016. 1–72 (American CancerSociety, 2016).
Li, S. et al. Estrogen receptor α is required for oviductal transport of embryos. Faseb J. https://doi.org/10.1096/Fj.201601128r (2017).
Canadian Cancer Society. Canadian Cancer Statistics 2016. 1–142 (Canadian CancerSociety, 2016).
MahmoodTYangP-CWestern blot: technique, theory, and trouble shootingN Am J Med Sci2012442943410.4103/1947-2714.94940230502593456489
MorrisSMTallquistMDRockCOCooperJADual roles for the Dab2 adaptor protein in embryonic development and kidney transportThe Embo Journal200221155515641:CAS:528:DC%2BD38XjtVOgtr0%3D10.1093/emboj/21.7.155511927540125955
SalehASMullaAFLuqmaniYAEstrogen receptor silencing induces epithelial to mesenchymal transition in human breast cancer cellsPlos One20116E2061010.1371/journal.pone.0020610217130353119661
FaziliZSunWMittelstaedtSCohenCXuXXDisabled-2 inactivation is an early step in ovarian tumorigenicityOncogene199918310431131:STN:280:DyaK1M3ntVajtQ%3D%3D10.1038/sj.onc.120264910340382
CosciaFIntegrative proteomic profiling of ovarian cancer cell lines reveals precursor cell associated proteins and functional statusNat Commun201672016NatCo...712645C1:CAS:528:DC%2BC28XhsVCht73J10.1038/ncomms12645275615515007461
ChenSEinspanierRSchoenJIn vitro mimicking of estrous cycle stages in porcine oviduct epithelium cells: estradiol and progesterone regulate differentiation, gene expression, and cellular functionBiology Of Reproduction2013895410.1095/biolreprod.113.10882923904510
ToneAAGene expression profiles of luteal phase fallopian tube epithelium from Brca mutation carriers resemble high-grade serous carcinomaClin. Cancer Res.200814406740781:CAS:528:DC%2BD1cXnvFylurs%3D10.1158/1078-0432.CCR-07-495918593983
CurtoMMcclatcheyAINf2/Merlin: A coordinator of receptor signalling and intercellular contactBr. J. Cancer2008982562621:CAS:528:DC%2BD1cXhtVKjsL4%3D10.1038/sj.bjc.660400217971776
TaoWMooreRSmithERXuXXHormonal induction and roles of Disabled-2 in lactation and involutionPlos One20149E11073710.1371/journal.pone.0110737253606234216001
ZhouWSlingerlandJMLinks between oestrogen receptor activation and proteolysis: relevance to hormone-regulated cancer therapyNat. Rev. Cancer20141426381:CAS:528:DC%2BC3sXhvFOltbzM10.1038/nrc362224505618
GupteAAPownallHJHamiltonDJEstrogen: an emerging regulator of insulin action and mitochondrial functionJ Diabetes Res2015201591658510.1155/2015/916585258839874391691
SingavarapuRBuchinskyNCheonDJOrsulicSWhole ovary immunohistochemistry for monitoring cell proliferation and ovulatory wound repair in the mouseReprod. Biol. Endocrinol.2010810.1186/1477-7827-8-98207128982929235
KingSMThe impact of ovulation on fallopian tube epithelial cells: evaluating three hypotheses connecting ovulation and serous ovarian cancerEndocr. Relat. Cancer2011186276421:CAS:528:DC%2BC3MXhsV2ns7nM10.1530/ERC-11-0107218137293638747
Auersperg, N. Ovarian surface epithelium: biology, endocrinology, and pathology. Endocrine Reviews 1–34 (2001).
BurdetteJEKurleySJKilenSMMayoKEWoodruffTKGonadotropin-induced superovulation drives ovarian surface epithelia proliferation in Cd1 miceEndocrinology2006147233823451:CAS:528:DC%2BD28XjvFOru7w%3D10.1210/en.2005-162916484319
RoforthMMAtkinsonEJLevinERKhoslaSMonroeDGDissection of estrogen receptor alpha signaling pathways in osteoblasts using R
16219_CR6
16219_CR7
16219_CR2
L Ferraro (16219_CR24) 2012; 3
T Mahmood (16219_CR53) 2012; 4
16219_CR1
16219_CR4
16219_CR3
MF Fathalla (16219_CR10) 1971; 2
W Tao (16219_CR16) 2014; 9
DH Yang (16219_CR20) 2002; 251
LSM Gulliver (16219_CR12) 2012; 77
A Okada (16219_CR45) 2004; 32
JE Burdette (16219_CR38) 2006; 147
MM Roforth (16219_CR49) 2014; 9
16219_CR14
IH Roland (16219_CR19) 2003; 98
LF Gamwell (16219_CR51) 2012; 87
A Chao (16219_CR28) 2012; 31
SM King (16219_CR44) 2011; 18
CW Mccloskey (16219_CR50) 2014; 4
S Chen (16219_CR46) 2013; 89
KC Choi (16219_CR11) 2001; 142
L Plaino (16219_CR13) 2000; 14
Z Fazili (16219_CR17) 1999; 18
V Bourdeau (16219_CR23) 2004; 18
R Singavarapu (16219_CR39) 2010; 8
16219_CR43
F Coscia (16219_CR8) 2016; 7
W Zhou (16219_CR22) 2014; 14
D-H Yang (16219_CR21) 2006; 169
AS Saleh (16219_CR56) 2011; 6
M Serrano (16219_CR36) 1997; 88
S Torre Della (16219_CR30) 2014; 10
AA Gupte (16219_CR47) 2015; 2015
M Curto (16219_CR34) 2008; 98
BA Hocevar (16219_CR35) 2003; 22
J Sassarini (16219_CR48) 2015; 44
CA Stewart (16219_CR42) 2012; 55
AI Mcclatchey (16219_CR32) 2012; 24
SC Hewitt (16219_CR52) 2010; 24
CM Klinge (16219_CR25) 2009; 10
Z Zhang (16219_CR18) 2014; 30
B St Croix (16219_CR33) 1998; 142
D Lanoix (16219_CR55) 2012; 33
SM Morris (16219_CR40) 2002; 21
AA Tone (16219_CR41) 2008; 14
GM Aldridge (16219_CR54) 2008; 172
L Du (16219_CR27) 2014; 33
S Courtois-Cox (16219_CR29) 2008; 27
16219_CR26
SH Hong (16219_CR31) 2004; 18
R Moore (16219_CR37) 2013; 13
LA Laviolette (16219_CR5) 2010; 151
DH Yang (16219_CR15) 2007; 282
16219_CR9
References_xml – reference: CosciaFIntegrative proteomic profiling of ovarian cancer cell lines reveals precursor cell associated proteins and functional statusNat Commun201672016NatCo...712645C1:CAS:528:DC%2BC28XhsVCht73J10.1038/ncomms12645275615515007461
– reference: TaoWMooreRSmithERXuXXHormonal induction and roles of Disabled-2 in lactation and involutionPlos One20149E11073710.1371/journal.pone.0110737253606234216001
– reference: American Cancer Society. Cancer Facts And Figures 2016. 1–72 (American CancerSociety, 2016).
– reference: ChoiKCKangSKTaiCJAuerspergNLeungPCEstradiol up-regulates antiapoptotic Bcl-2 messenger ribonucleic acid and protein in tumorigenic ovarian surface epithelium cellsEndocrinology2001142235123601:CAS:528:DC%2BD3MXjvFGgu7Y%3D10.1210/endo.142.6.814411356682
– reference: KingSMThe impact of ovulation on fallopian tube epithelial cells: evaluating three hypotheses connecting ovulation and serous ovarian cancerEndocr. Relat. Cancer2011186276421:CAS:528:DC%2BC3MXhsV2ns7nM10.1530/ERC-11-0107218137293638747
– reference: FaziliZSunWMittelstaedtSCohenCXuXXDisabled-2 inactivation is an early step in ovarian tumorigenicityOncogene199918310431131:STN:280:DyaK1M3ntVajtQ%3D%3D10.1038/sj.onc.120264910340382
– reference: MorrisSMTallquistMDRockCOCooperJADual roles for the Dab2 adaptor protein in embryonic development and kidney transportThe Embo Journal200221155515641:CAS:528:DC%2BD38XjtVOgtr0%3D10.1093/emboj/21.7.155511927540125955
– reference: LavioletteLA17β-Estradiol accelerates tumor onset and decreases survival in a transgenic mouse model of ovarian cancerEndocrinology20101519299381:CAS:528:DC%2BC3cXjvVKqsL8%3D10.1210/en.2009-060220056833
– reference: St CroixBE-cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitorp27(Kip1)The Journal Of Cell Biology199814255757110.1083/jcb.142.2.557
– reference: Ellison, T. N. A. L. Ovarian Cancer: Survival Statistics. 1–9 (Statistics Canada, 2015).
– reference: GulliverLSMHurstPRRepeat estradiol exposure differentially regulates protein expression patterns for estrogen receptor and e-cadherin in older mouse ovarian surface epithelium: implications for replacement and adjuvant hormone therapies?Steroids2012776746851:CAS:528:DC%2BC38Xkt1ymtrw%3D10.1016/j.steroids.2012.02.01522406420
– reference: YangDHDisabled-2 is essential for endodermal cell positioning and structure formation during mouse embryogenesisDev. Biol.200225127441:CAS:528:DC%2BD38XotFGgsbo%3D10.1006/dbio.2002.081012413896
– reference: SerranoMLinAWMccurrachMEBeachDLoweSWOncogenic Ras Provokes premature cell senescence associated with accumulation of P53 and P16ink4aCell1997885936021:CAS:528:DyaK2sXhvVSit7k%3D10.1016/S0092-8674(00)81902-99054499
– reference: Auersperg, N. Ovarian surface epithelium as a source of ovarian cancers: unwarranted speculation or evidence-based hypothesis? Gynecologic Oncology 1–6, https://doi.org/10.1016/J.Ygyno.2013.03.021 (2013).
– reference: RoforthMMAtkinsonEJLevinERKhoslaSMonroeDGDissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-SequencingPlos One20149E959872014PLoSO...995987R10.1371/journal.pone.0095987247768424002480
– reference: DuLMir-93-directed downregulation of Dab2 defines a novel oncogenic pathway in lung cancerOncogene201433430743151:CAS:528:DC%2BC3sXhsVeqsLrI10.1038/onc.2013.38124037530
– reference: Courtois-CoxSJonesSLCichowskiKMany roads lead to oncogene-induced senescenceOncogene200827280128091:CAS:528:DC%2BD1cXltlSgs7w%3D10.1038/sj.onc.121095018193093
– reference: CurtoMMcclatcheyAINf2/Merlin: A coordinator of receptor signalling and intercellular contactBr. J. Cancer2008982562621:CAS:528:DC%2BD1cXhtVKjsL4%3D10.1038/sj.bjc.660400217971776
– reference: Torre DellaSBenedusiVFontanaRMaggiAEnergy metabolism and fertility - a balance preserved for female healthNature Reviews Endocrinology201410132310.1038/nrendo.2013.203
– reference: YangD-HDisabled-2 heterozygous mice are predisposed to endometrial and ovarian tumorigenesis and exhibit sex-biased embryonic lethality in a P53-null backgroundThe American Journal Of Pathology20061692582671:CAS:528:DC%2BD28XnslSntb8%3D10.2353/ajpath.2006.060036168163781698752
– reference: HongSHExpression of estrogen receptor-alpha and -beta, glucocorticoid receptor, and progesterone receptor genes in human embryonic stem cells and embryoid bodiesMol. Cells2004183203251:CAS:528:DC%2BD2MXpsFartA%3D%3D15650328
– reference: Collaborative Group On Epidemiological Studies Of Ovarian Cancer. Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies. Lancet385, 1835–1842 (2015).
– reference: MooreRCaiKQTaoWSmithERXuXXdifferential requirement for Dab2 in the development of embryonic and extra-embryonic tissuesBmc Developmental Biology20131310.1186/1471-213X-13-39241680303924344
– reference: FathallaMFIncessant ovulation-a factor in ovarian neoplasia?Lancet197121631:STN:280:DyaE3M3ls12ltw%3D%3D10.1016/S0140-6736(71)92335-X4104488
– reference: Auersperg, N. Ovarian surface epithelium: biology, endocrinology, and pathology. Endocrine Reviews 1–34 (2001).
– reference: McclatcheyAIYapASContact inhibition (of proliferation) reduxCurr. Opin. Cell Biol.2012246856941:CAS:528:DC%2BC38XhtVyktL7J10.1016/j.ceb.2012.06.00922835462
– reference: RolandIHLoss of surface and cyst epithelial basement membranes and preneoplastic morphologic changes in prophylactic oophorectomiesCancer2003982607262310.1002/cncr.1184714669280
– reference: SalehASMullaAFLuqmaniYAEstrogen receptor silencing induces epithelial to mesenchymal transition in human breast cancer cellsPlos One20116E2061010.1371/journal.pone.0020610217130353119661
– reference: Klinge, C. M. miRNAs regulated by estrogens, tamoxifen, and endocrine disruptors and their downstream gene targets. Molecular And Cellular Endocrinology, https://doi.org/10.1016/J.Mce.2015.01.035 (2015).
– reference: ZhouWSlingerlandJMLinks between oestrogen receptor activation and proteolysis: relevance to hormone-regulated cancer therapyNat. Rev. Cancer20141426381:CAS:528:DC%2BC3sXhvFOltbzM10.1038/nrc362224505618
– reference: ChaoARegulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2Oncogene2012317647751:CAS:528:DC%2BC3MXotlCktLw%3D10.1038/onc.2011.26921725366
– reference: ZhangZChenYTangJXieXFrequent loss expression of Dab2 and promotor hypermethylation in human cancers: a meta-analysis and systematic reviewPak J Med Sci201430432437247721573999024
– reference: ChenSEinspanierRSchoenJIn vitro mimicking of estrous cycle stages in porcine oviduct epithelium cells: estradiol and progesterone regulate differentiation, gene expression, and cellular functionBiology Of Reproduction2013895410.1095/biolreprod.113.10882923904510
– reference: SassariniJLumsdenMAOestrogen replacement in postmenopausal womenAge Ageing20154455155810.1093/ageing/afv06926070875
– reference: Canadian Cancer Society. Canadian Cancer Statistics 2016. 1–142 (Canadian CancerSociety, 2016).
– reference: KlingeCMEstrogen regulation of microrna expressionCurr. Genomics2009101691831:CAS:528:DC%2BD1MXmslans7o%3D10.2174/138920209788185289198819102705850
– reference: Webb, P. M. & Jordan, S. J. Epidemiology of epithelial ovarian cancer. Best Pract Res Clin Obstet Gynaecol, https://doi.org/10.1016/J.Bpobgyn.2016.08.006 (2016).
– reference: SingavarapuRBuchinskyNCheonDJOrsulicSWhole ovary immunohistochemistry for monitoring cell proliferation and ovulatory wound repair in the mouseReprod. Biol. Endocrinol.2010810.1186/1477-7827-8-98207128982929235
– reference: OkadaARole of Foxj1 and estrogen receptor alpha in ciliated epithelial cell differentiation of the neonatal oviductJ. Mol. Endocrinol.2004326156251:CAS:528:DC%2BD2cXlslWjt7w%3D10.1677/jme.0.032061515171704
– reference: GamwellLFCollinsOVanderhydenBCThe mouse ovarian surface epithelium contains a population of Ly6a (Sca-1) expressing progenitor cells that are regulated by ovulation-associated factorsBiology Of Reproduction2012878010.1093/biolreprod/87.s1.8022914315
– reference: HocevarBAHowePHRegulation of the Wnt signaling pathway by Disabled-2 (Dab2)The Embo Journal200322308430941:CAS:528:DC%2BD3sXks1Wru74%3D10.1093/emboj/cdg28612805222162138
– reference: HewittSCBiological and biochemical consequences of global deletion of exon 3 from the ER alpha geneFaseb J.201024466046671:CAS:528:DC%2BC3cXhsFOms7zO10.1096/fj.10-163428206679772992373
– reference: AldridgeGMPodrebaracDMGreenoughWTWeilerIJThe use of total protein stains as loading controls: an alternative to high-abundance single-protein controls in semi-quantitative immunoblottingJ. Neurosci. Methods20081722502541:CAS:528:DC%2BD1cXosVyls7w%3D10.1016/j.jneumeth.2008.05.003185717322567873
– reference: YangDHXuXXdisabled-2 is an epithelial surface positioning geneJ. Biol. Chem.200728213114131221:CAS:528:DC%2BD2sXksVShsLo%3D10.1074/jbc.M61135620017339320
– reference: FerraroLEffects of oestrogen on microrna expression in hormone-responsive breast cancer cellsHorm Canc2012365781:CAS:528:DC%2BC38XmsF2msrk%3D10.1007/s12672-012-0102-1
– reference: BurdetteJEKurleySJKilenSMMayoKEWoodruffTKGonadotropin-induced superovulation drives ovarian surface epithelia proliferation in Cd1 miceEndocrinology2006147233823451:CAS:528:DC%2BD28XjvFOru7w%3D10.1210/en.2005-162916484319
– reference: MahmoodTYangP-CWestern blot: technique, theory, and trouble shootingN Am J Med Sci2012442943410.4103/1947-2714.94940230502593456489
– reference: BourdeauVGenome-wide identification of high-affinity estrogen response elements in human and mouseMolecular Endocrinology200418141114271:CAS:528:DC%2BD2cXksl2ju7c%3D10.1210/me.2003-044115001666
– reference: ToneAAGene expression profiles of luteal phase fallopian tube epithelium from Brca mutation carriers resemble high-grade serous carcinomaClin. Cancer Res.200814406740781:CAS:528:DC%2BD1cXnvFylurs%3D10.1158/1078-0432.CCR-07-495918593983
– reference: PlainoLOvarian follicular fluid contains immunoreactive estriol: lack of correlation with estradiol concentrationsGynecol. Endocrinol.2000142312351:STN:280:DC%2BD3M7ltVKjtA%3D%3D10.3109/0951359000916768611075291
– reference: Li, S. et al. Estrogen receptor α is required for oviductal transport of embryos. Faseb J. https://doi.org/10.1096/Fj.201601128r (2017).
– reference: LanoixDStability of reference proteins in human placenta: general protein stains are the benchmarkPlacenta2012331511561:CAS:528:DC%2BC38Xit1eisLw%3D10.1016/j.placenta.2011.12.00822244735
– reference: StewartCABehringerRRMouse oviduct developmentResults Probl Cell Differ20125524726210.1007/978-3-642-30406-4_1422918811
– reference: Coetzee, S. G. et al. Cell type specific enrichment of risk associated regulatory elements at ovarian cancer susceptibility loci. Hum. Mol. Genet. https://doi.org/10.1093/Hmg/Ddv101 (2015).
– reference: MccloskeyCWA new spontaneously transformed syngeneic model of high-grade serous ovarian cancer with a tumor-initiating cell populationFront Oncol201445310.3389/fonc.2014.00053246727743957277
– reference: GupteAAPownallHJHamiltonDJEstrogen: an emerging regulator of insulin action and mitochondrial functionJ Diabetes Res2015201591658510.1155/2015/916585258839874391691
– ident: 16219_CR4
  doi: 10.1016/S0140-6736(14)61687-1
– ident: 16219_CR6
  doi: 10.1016/J.Bpobgyn.2016.08.006
– volume: 6
  start-page: E20610
  year: 2011
  ident: 16219_CR56
  publication-title: Plos One
  doi: 10.1371/journal.pone.0020610
– ident: 16219_CR3
– volume: 30
  start-page: 432
  year: 2014
  ident: 16219_CR18
  publication-title: Pak J Med Sci
– volume: 24
  start-page: 685
  year: 2012
  ident: 16219_CR32
  publication-title: Curr. Opin. Cell Biol.
  doi: 10.1016/j.ceb.2012.06.009
– volume: 282
  start-page: 13114
  year: 2007
  ident: 16219_CR15
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M611356200
– ident: 16219_CR1
  doi: 10.1155/2016/7348239
– volume: 18
  start-page: 1411
  year: 2004
  ident: 16219_CR23
  publication-title: Molecular Endocrinology
  doi: 10.1210/me.2003-0441
– volume: 14
  start-page: 231
  year: 2000
  ident: 16219_CR13
  publication-title: Gynecol. Endocrinol.
  doi: 10.3109/09513590009167686
– volume: 77
  start-page: 674
  year: 2012
  ident: 16219_CR12
  publication-title: Steroids
  doi: 10.1016/j.steroids.2012.02.015
– volume: 9
  start-page: E95987
  year: 2014
  ident: 16219_CR49
  publication-title: Plos One
  doi: 10.1371/journal.pone.0095987
– volume: 169
  start-page: 258
  year: 2006
  ident: 16219_CR21
  publication-title: The American Journal Of Pathology
  doi: 10.2353/ajpath.2006.060036
– ident: 16219_CR26
  doi: 10.1016/J.Mce.2015.01.035
– volume: 88
  start-page: 593
  year: 1997
  ident: 16219_CR36
  publication-title: Cell
  doi: 10.1016/S0092-8674(00)81902-9
– volume: 251
  start-page: 27
  year: 2002
  ident: 16219_CR20
  publication-title: Dev. Biol.
  doi: 10.1006/dbio.2002.0810
– volume: 22
  start-page: 3084
  year: 2003
  ident: 16219_CR35
  publication-title: The Embo Journal
  doi: 10.1093/emboj/cdg286
– ident: 16219_CR7
  doi: 10.1016/J.Ygyno.2013.03.021
– volume: 44
  start-page: 551
  year: 2015
  ident: 16219_CR48
  publication-title: Age Ageing
  doi: 10.1093/ageing/afv069
– volume: 33
  start-page: 151
  year: 2012
  ident: 16219_CR55
  publication-title: Placenta
  doi: 10.1016/j.placenta.2011.12.008
– volume: 27
  start-page: 2801
  year: 2008
  ident: 16219_CR29
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1210950
– volume: 14
  start-page: 4067
  year: 2008
  ident: 16219_CR41
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-07-4959
– volume: 18
  start-page: 320
  year: 2004
  ident: 16219_CR31
  publication-title: Mol. Cells
  doi: 10.1016/S1016-8478(23)13119-0
– ident: 16219_CR9
  doi: 10.1093/Hmg/Ddv101
– volume: 142
  start-page: 557
  year: 1998
  ident: 16219_CR33
  publication-title: The Journal Of Cell Biology
  doi: 10.1083/jcb.142.2.557
– ident: 16219_CR43
  doi: 10.1096/Fj.201601128r
– volume: 32
  start-page: 615
  year: 2004
  ident: 16219_CR45
  publication-title: J. Mol. Endocrinol.
  doi: 10.1677/jme.0.0320615
– volume: 33
  start-page: 4307
  year: 2014
  ident: 16219_CR27
  publication-title: Oncogene
  doi: 10.1038/onc.2013.381
– volume: 2
  start-page: 163
  year: 1971
  ident: 16219_CR10
  publication-title: Lancet
  doi: 10.1016/S0140-6736(71)92335-X
– volume: 98
  start-page: 2607
  year: 2003
  ident: 16219_CR19
  publication-title: Cancer
  doi: 10.1002/cncr.11847
– volume: 4
  start-page: 429
  year: 2012
  ident: 16219_CR53
  publication-title: N Am J Med Sci
  doi: 10.4103/1947-2714.94940
– volume: 13
  year: 2013
  ident: 16219_CR37
  publication-title: Bmc Developmental Biology
  doi: 10.1186/1471-213X-13-39
– volume: 98
  start-page: 256
  year: 2008
  ident: 16219_CR34
  publication-title: Br. J. Cancer
  doi: 10.1038/sj.bjc.6604002
– volume: 7
  year: 2016
  ident: 16219_CR8
  publication-title: Nat Commun
  doi: 10.1038/ncomms12645
– volume: 10
  start-page: 13
  year: 2014
  ident: 16219_CR30
  publication-title: Nature Reviews Endocrinology
  doi: 10.1038/nrendo.2013.203
– volume: 147
  start-page: 2338
  year: 2006
  ident: 16219_CR38
  publication-title: Endocrinology
  doi: 10.1210/en.2005-1629
– volume: 18
  start-page: 3104
  year: 1999
  ident: 16219_CR17
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1202649
– volume: 18
  start-page: 627
  year: 2011
  ident: 16219_CR44
  publication-title: Endocr. Relat. Cancer
  doi: 10.1530/ERC-11-0107
– volume: 2015
  start-page: 916585
  year: 2015
  ident: 16219_CR47
  publication-title: J Diabetes Res
  doi: 10.1155/2015/916585
– volume: 31
  start-page: 764
  year: 2012
  ident: 16219_CR28
  publication-title: Oncogene
  doi: 10.1038/onc.2011.269
– volume: 89
  start-page: 54
  year: 2013
  ident: 16219_CR46
  publication-title: Biology Of Reproduction
  doi: 10.1095/biolreprod.113.108829
– ident: 16219_CR14
  doi: 10.1210/er.22.2.255
– volume: 4
  start-page: 53
  year: 2014
  ident: 16219_CR50
  publication-title: Front Oncol
  doi: 10.3389/fonc.2014.00053
– ident: 16219_CR2
– volume: 14
  start-page: 26
  year: 2014
  ident: 16219_CR22
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc3622
– volume: 55
  start-page: 247
  year: 2012
  ident: 16219_CR42
  publication-title: Results Probl Cell Differ
  doi: 10.1007/978-3-642-30406-4_14
– volume: 151
  start-page: 929
  year: 2010
  ident: 16219_CR5
  publication-title: Endocrinology
  doi: 10.1210/en.2009-0602
– volume: 24
  start-page: 4660
  year: 2010
  ident: 16219_CR52
  publication-title: Faseb J.
  doi: 10.1096/fj.10-163428
– volume: 3
  start-page: 65
  year: 2012
  ident: 16219_CR24
  publication-title: Horm Canc
  doi: 10.1007/s12672-012-0102-1
– volume: 172
  start-page: 250
  year: 2008
  ident: 16219_CR54
  publication-title: J. Neurosci. Methods
  doi: 10.1016/j.jneumeth.2008.05.003
– volume: 9
  start-page: E110737
  year: 2014
  ident: 16219_CR16
  publication-title: Plos One
  doi: 10.1371/journal.pone.0110737
– volume: 142
  start-page: 2351
  year: 2001
  ident: 16219_CR11
  publication-title: Endocrinology
  doi: 10.1210/endo.142.6.8144
– volume: 8
  year: 2010
  ident: 16219_CR39
  publication-title: Reprod. Biol. Endocrinol.
  doi: 10.1186/1477-7827-8-98
– volume: 87
  start-page: 80
  year: 2012
  ident: 16219_CR51
  publication-title: Biology Of Reproduction
  doi: 10.1093/biolreprod/87.s1.80
– volume: 10
  start-page: 169
  year: 2009
  ident: 16219_CR25
  publication-title: Curr. Genomics
  doi: 10.2174/138920209788185289
– volume: 21
  start-page: 1555
  year: 2002
  ident: 16219_CR40
  publication-title: The Embo Journal
  doi: 10.1093/emboj/21.7.1555
SSID ssj0000529419
Score 2.2595592
Snippet Estrogen replacement therapy increases the risk of human ovarian cancer and exogenous estradiol accelerates the onset of ovarian cancer in mouse models. This...
SourceID pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 16702
SubjectTerms 13
13/106
13/51
14/19
14/63
17β-Estradiol
38
38/109
38/61
631/443/494/2732/2730
631/67/1517/1709
631/80/304
64
64/60
82/1
Adaptor Proteins, Signal Transducing
Adaptor Proteins, Vesicular Transport - biosynthesis
Adaptor Proteins, Vesicular Transport - genetics
Animal models
Animals
Apoptosis Regulatory Proteins
Carcinoma, Ovarian Epithelial - chemically induced
Carcinoma, Ovarian Epithelial - genetics
Carcinoma, Ovarian Epithelial - metabolism
Carcinoma, Ovarian Epithelial - pathology
Cell proliferation
Cell Transformation, Neoplastic - chemically induced
Cell Transformation, Neoplastic - genetics
Cell Transformation, Neoplastic - metabolism
Cell Transformation, Neoplastic - pathology
Contact inhibition
Dysplasia
Epithelial Cells - metabolism
Epithelial Cells - pathology
Epithelium
Epithelium - metabolism
Epithelium - pathology
Estradiol - adverse effects
Estradiol - pharmacology
Estrogen receptors
Estrogen replacement therapy
Estrogens
Female
Genetic transformation
Hormone replacement therapy
Humanities and Social Sciences
Humans
Mice
Mice, Knockout
miRNA
multidisciplinary
Ovarian cancer
Ovarian Neoplasms - chemically induced
Ovarian Neoplasms - genetics
Ovarian Neoplasms - metabolism
Ovarian Neoplasms - pathology
Ovary - metabolism
Ovary - pathology
Science
Science (multidisciplinary)
Senescence
Tumor Suppressor Proteins - biosynthesis
Tumor Suppressor Proteins - genetics
Tumors
Title 17β-Estradiol sensitizes ovarian surface epithelium to transformation by suppressing Disabled-2 expression
URI https://link.springer.com/article/10.1038/s41598-017-16219-2
https://www.ncbi.nlm.nih.gov/pubmed/29196616
https://www.proquest.com/docview/1970989600
https://www.proquest.com/docview/1971688736
https://pubmed.ncbi.nlm.nih.gov/PMC5711839
Volume 7
WOSCitedRecordID wos000416938200010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: DOA
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: M~E
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVPQU
  databaseName: Biological Science Database
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: M7P
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/biologicalscijournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: 7X7
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: BENPR
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Publicly Available Content Database
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: PIMPY
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Science Database
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: M2P
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/sciencejournals
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR3LbtQwcERbkLiUNwTKykjcIGpsJ7FzqnhsBRJdRQik5RQ5jlNWLMmyyVYtn9UP4ZsYO9nQpaIXLjlkJkqceXg8T4DnOfINK3Tkq5ILPKAkVuY095mSgbbtUoLcNXH9ICYTOZ0mae9wa_q0yrVOdIq6qLX1ke_TRASJRHs7OFj88O3UKBtd7UdobMGO7ZLAXepeOvhYbBQrpElfKxNwud_gfmVrylA10xiF1Web-9ElI_NyruRfAVO3Dx3e-t8V3Ibd3gIlrzqWuQPXTHUXbnQzKc_uwTcqfp37Y-sBKfAeaWyGezv7aRpSn-DBWlWkWS1LpQ0xC1vQMZ-tvpO2Ju0FE7iuSH6GeIsuzbY6Jm9tL9-5KXxGzGmffFvdh8-H409v3vn9RAZfhyJofRWUSkXCGK4KE-bKoDmlFJMqzCMdRmgd5KWiYamjhHNeyiRXqFJ0mQRMC6Y5fwDbVV2ZR0CErYCVBZ7A0WSLcvw5kSpFISmNNXJ36AFd0yXTfbtyOzVjnrmwOZdZR8sMaZk5WmbMgxfDM4uuWceV2HtrOmW94DbZHyJ58GwAo8jZOIqqTL1yODRG5cxjDx523DG8jiWo0mKKELHBNwOCbee9CalmX11b70hQa6568HLNYRc-65-reHz1Kp7ATea43Sbg7MF2u1yZp3Bdn7SzZjmCLTEV7ipHsPN6PEk_jpxXAq9HLB05cUJI-v4o_fIb2cYl9A
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Jb9QwFH6qCggu7EuggJHgBFZjZ7FzQAjRVq06jHooUm_BcRwYMSTDJFMYfhQHfgi_iWdnoUNFbz1wjV-UOPne4rcCPM0QNzzXEVVFIPCAklie0wHlSvratkvxM9fEdSTGY3l0lByswY--FsamVfYy0QnqvNLWR77JEuEnEu1t_9XsC7VTo2x0tR-h0cJi3yy_4pGtfrm3hf_3Gec724dvdmk3VYDqUPgNVX6hVCSMCVRuwkwZNAmU4lKFWaTDCDVcVigWFjrCs35QyCRTyBa6SHyuBdfWAYoi_wKaEVy6VMGDwadjo2YhS7raHD-QmzXqR1vDhqqAxSgcKF_Vf6eM2tO5mX8FaJ3e27n2v32x63C1s7DJ65YlbsCaKW_CpXbm5vIWfGLi10-6bT08OV4jtc3gbybfTU2qY4XsWJJ6MS-UNsTMbMHKdLL4TJqKNCdM_Kok2RLpZm0acfmBbNlexVOTU07Mty65uLwN785lp3dgvaxKcw-IsBW-MhcSTdowyvBnRKoQuWQs1si9oQesx0Gqu3bsdirINHVpAYFMW-ykiJ3UYSflHjwf7pm1zUjOpN7ocZF2gqlO_4DCgyfDMooUGydSpakWjobFqHyC2IO7LRqHx_EERXbMcEWs4HQgsO3KV1fKyUfXtjwSzJrjHrzoEX3itf65i_tn7-IxXN49fDtKR3vj_QdwhTtOs8lGG7DezBfmIVzUx82knj9yrErg_Xkj_TctnX37
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB5V5SEuvAuBAkaCE0QbO8naOSCE2K6oWq32AFJvwXEcWLEkyyZbWH4WR34Ev4mZvOhS0VsPXGNHiZNvHh5_MwPwJEHciNSErs58iRuUiGTO-K7QyjNULsVL6iKuh3IyUUdH0XQLfna5MESr7HRirajTwlCMfMAj6UUK_W1vkLW0iOlo_HLxxaUOUnTS2rXTaCByYNdfcftWvtgf4b9-KsR47-3rN27bYcA1gfQqV3uZ1qG01tepDRJt0T3QWigdJKEJQrR2SaZ5kJkQ9_1-pqJEo4iYLPKEkcJQMBTV_wVJRctr2uC0j-_QCVrAozZPx_PVoERbSflsaBb4EBWFKzZt4SkH9zRP86_D2toGjq_9z1_vOlxtPW_2qhGVG7Bl85twqenFub4Fn7j89cPdo8hPitdYScz-avbdlqw41iimOStXy0wby-yCElnms9VnVhWsOuH6FzlL1jhv0dCL8w9sRDWM5zZ1BbPfWtJxfhvenctKd2A7L3J7F5ikzF-VSoWubhAm-GNCnclUcT40KNWBA7zDRGzaMu3ULWQe13QBX8UNjmLEUVzjKBYOPOvvWTRFSs6cvdthJG4VVhn_AYgDj_thVDV0fqRzW6zqOXyIRskfOnCnQWb_OBGhKh9yHJEbmO0nUBnzzZF89rEuZx5KTm66A887dJ94rX-u4t7Zq3gElxHg8eH-5OA-XBG10BEHaRe2q-XKPoCL5rialcuHtdQyeH_eQP8NPQyGuA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=17%CE%B2-Estradiol+sensitizes+ovarian+surface+epithelium+to+transformation+by+suppressing+Disabled-2+expression&rft.jtitle=Scientific+reports&rft.au=Vuong%2C+Nhung+H&rft.au=Salah+Salah%2C+Omar&rft.au=Vanderhyden%2C+Barbara+C&rft.date=2017-12-01&rft.eissn=2045-2322&rft.volume=7&rft.issue=1&rft.spage=16702&rft_id=info:doi/10.1038%2Fs41598-017-16219-2&rft_id=info%3Apmid%2F29196616&rft.externalDocID=29196616
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon